Journal of Cachexia Sarcopenia and Muscle

- In a groundbreaking study, Professor Yea’s DGIST research team verified the effectiveness of the anti-GFRAL human antibodies in improving chemotherapy-induced cancer cachexia - The team presents a candidate antibody for managing cancer cachexia, a condition without an approved and effective therapy worldwide